In order to investigate the contribution of PON2 to BC tumorigenesis by promoting apoptotic escape, caspase-3 and caspase-8 activities were evaluated in T24 cells expressing either reduced or elevated PON2 levels, as well as corresponding controls, upon treatment for 24 h with chemotherapeutic drugs. The gene discussed is CASP3; the disease is breast cancer.